pentobarbital will minimize the extent or impact of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Loss of, or lowered response to tofacitinib may come about when coadministered with strong CYP3A4 inducersfentanyl transmucosal and pentobarbital both of those enhance sedation. Stay away from or Use